Voya Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
38,414
-1,094
-3% -$29.1K 0.1% 87
2025
Q4
$988K Sell
39,508
-1,448
-4% -$36.5K 0.09% 100
2025
Q3
$977K Sell
40,956
-4,825
-11% -$119K 0.09% 97
2025
Q2
$1.11M Buy
45,781
+2,790
+6% +$65.1K 0.11% 92
2025
Q1
$1.08M Buy
42,991
+1,703
+4% +$44.6K 0.12% 88
2024
Q4
$1.09M Buy
41,288
+1,841
+5% +$49.9K 0.12% 84
2024
Q3
$1.15M Buy
39,447
+704
+2% +$20.5K 0.12% 81
2024
Q2
$1.08M Buy
38,743
+894
+2% +$24.6K 0.12% 79
2024
Q1
$1.05M Buy
37,849
+3,027
+9% +$84K 0.12% 77
2023
Q4
$1M Buy
34,822
+361
+1% +$10.9K 0.12% 77
2023
Q3
$1.11M Buy
34,461
+13,095
+61% +$463K 0.14% 59
2023
Q2
$772K Buy
21,366
+1,747
+9% +$68K 0.09% 97
2023
Q1
$792K Buy
19,619
+533
+3% +$23K 0.1% 97
2022
Q4
$980K Sell
19,086
-1,210
-6% -$58K 0.13% 78
2022
Q3
$896K Buy
20,296
+882
+5% +$42.9K 0.12% 92
2022
Q2
$989K Buy
19,414
+1,203
+7% +$61.3K 0.12% 82
2022
Q1
$955K Buy
18,211
+230
+1% +$11.9K 0.11% 93
2021
Q4
$1.05M Sell
17,981
-14,604
-45% -$724K 0.12% 88
2021
Q3
$1.42M Sell
32,585
-4,326
-12% -$192K 0.17% 55
2021
Q2
$1.44M Sell
36,911
-197,357
-84% -$7.67M 0.19% 51
2021
Q1
$8.46M Buy
234,268
+6,531
+3% +$232K 0.33% 45
2020
Q4
$8.37M Sell
227,737
-10,698
-4% -$392K 0.36% 39
2020
Q3
$8.18M Sell
238,435
-16,066
-6% -$563K 0.41% 40
2020
Q2
$7.88M Buy
254,501
+4,734
+2% +$161K 0.41% 41
2020
Q1
$7.74M Sell
249,767
-14,256
-5% -$486K 0.43% 39
2019
Q4
$9.75M Buy
264,023
+24,135
+10% +$860K 0.48% 39
2019
Q3
$8.24M Buy
239,888
+44,550
+23% +$1.62M 0.44% 44
2019
Q2
$8.05M Buy
195,338
+12,417
+7% +$493K 0.43% 47
2019
Q1
$7.34M Buy
182,921
+8,796
+5% +$352K 0.43% 50
2018
Q4
$7.1M Sell
174,125
-1,486
-0.8% -$61.7K 0.47% 47
2018
Q3
$7.31M Buy
175,611
+11,287
+7% +$435K 0.43% 44
2018
Q2
$5.67M Sell
164,324
-2,890
-2% -$98.8K 0.37% 54
2018
Q1
$5.6M Sell
167,214
-10,994
-6% -$378K 0.37% 56
2017
Q4
$6.15M Sell
178,208
-16,277
-8% -$555K 0.4% 53
2017
Q3
$6.57M Sell
194,485
-223
-0.1% -$7.17K 0.44% 46
2017
Q2
$6.21M Buy
194,708
+10,330
+6% +$326K 0.44% 47
2017
Q1
$6M Buy
184,378
+32,806
+22% +$1.03M 0.47% 43
2016
Q4
$4.67M Buy
151,572
+38,593
+34% +$1.18M 0.41% 50
2016
Q3
$3.57M Buy
112,979
+54,093
+92% +$1.81M 0.36% 55
2016
Q2
$1.96M Buy
58,886
+4,800
+9% +$153K 0.23% 84
2016
Q1
$1.54M Buy
54,086
+7,492
+16% +$214K 0.22% 89
2015
Q4
$1.45M Buy
46,594
+5,230
+13% +$165K 0.21% 82
2015
Q3
$1.22M Buy
41,364
+52
+0.1% +$1.67K 0.22% 82
2015
Q2
$1.32M Buy
41,312
+1,646
+4% +$53.6K 0.23% 81
2015
Q1
$1.32M Buy
+39,666
New +$1.26M 0.26% 91

Other funds holding PFE

Voya Financial Advisors's PFE Position: Q1 2026 in Review

Voya Financial Advisors reduced its Pfizer (PFE) stake by 2.8% in Q1 2026, selling an estimated $29.1K and leaving 38,414 shares worth $1.04M. The position accounts for 0.1% of the portfolio, ranked #87.

Voya Financial Advisors first reported a position in PFE in Q1 2015 and has held it in 45 quarters since. The position peaked at $9.75M in Q4 2019. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Voya Financial Advisors held 38,414 shares of Pfizer worth $1.04M as of Q1 2026.
  • Voya Financial Advisors sold 1,094 Pfizer shares in Q1 2026, an estimated $29.1K.
  • Pfizer made up 0.1% of Voya Financial Advisors's portfolio in Q1 2026, its #87 holding.
  • Voya Financial Advisors first reported a position in Pfizer in Q1 2015 and has held it in 45 quarters since.
  • Voya Financial Advisors's Pfizer position peaked at $9.75M in Q4 2019.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.